Logo image of WRE

WASHINGTON REIT (WRE) Stock Fundamental Analysis

USA - NYSE:WRE - US9396531017 - REIT

17.57 USD
-0.38 (-2.12%)
Last: 10/19/2022, 8:04:00 PM
17.57 USD
0 (0%)
After Hours: 10/19/2022, 8:04:00 PM
Fundamental Rating

2

Overall WRE gets a fundamental rating of 2 out of 10. We evaluated WRE against 130 industry peers in the Diversified REITs industry. WRE may be in some trouble as it scores bad on both profitability and health. WRE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year WRE has reported negative net income.
WRE had a positive operating cash flow in the past year.
WRE Yearly Net Income VS EBIT VS OCF VS FCFWRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M -200M -400M

1.2 Ratios

Industry RankSector Rank
ROA 0.41%
ROE 0.61%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WRE Yearly ROA, ROE, ROICWRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5 10 15 20 25

1.3 Margins

WRE's Profit Margin has declined in the last couple of years.
WRE's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM -1.01%
PM (TTM) 4.25%
GM N/A
OM growth 3Y-66.06%
OM growth 5Y-50.73%
PM growth 3Y-13.86%
PM growth 5Y-32.78%
GM growth 3YN/A
GM growth 5YN/A
WRE Yearly Profit, Operating, Gross MarginsWRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 50 100 150 200

More info and screens

1

2. Health

2.1 Basic Checks

WRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
WRE has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, WRE has an improved debt to assets ratio.
WRE Yearly Shares OutstandingWRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
WRE Yearly Total Debt VS Total AssetsWRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

WRE has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.34%
WRE Yearly LT Debt VS Equity VS FCFWRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M 1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

4

3. Growth

3.1 Past

The earnings per share for WRE have decreased strongly by -16.67% in the last year.
Measured over the past years, WRE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -34.84% on average per year.
Looking at the last year, WRE shows a very negative growth in Revenue. The Revenue has decreased by -37.02% in the last year.
Measured over the past years, WRE shows a very negative growth in Revenue. The Revenue has been decreasing by -11.60% on average per year.
EPS 1Y (TTM)-16.67%
EPS 3Y-15.77%
EPS 5Y-34.84%
EPS Q2Q%-25%
Revenue 1Y (TTM)-37.02%
Revenue growth 3Y-16.61%
Revenue growth 5Y-11.6%
Sales Q2Q%-37.27%

3.2 Future

The Earnings Per Share is expected to grow by 9.38% on average over the next years. This is quite good.
Based on estimates for the next years, WRE will show a quite strong growth in Revenue. The Revenue will grow by 11.32% on average per year.
EPS Next Y-38.21%
EPS Next 2Y25.49%
EPS Next 3Y22.55%
EPS Next 5Y9.38%
Revenue Next Year10.03%
Revenue Next 2Y12.84%
Revenue Next 3Y11.27%
Revenue Next 5Y11.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WRE Yearly Revenue VS EstimatesWRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
WRE Yearly EPS VS EstimatesWRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WRE. In the last year negative earnings were reported.
Also next year WRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WRE Price Earnings VS Forward Price EarningsWRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.9
WRE Per share dataWRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as WRE's earnings are expected to grow with 22.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.49%
EPS Next 3Y22.55%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.97%, WRE has a reasonable but not impressive dividend return.
Compared to an average S&P500 Dividend Yield of 2.38, WRE pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.97%

5.2 History

The dividend of WRE decreases each year by -7.82%.
WRE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-7.82%
Div Incr YearsN/A
Div Non Decr YearsN/A
WRE Yearly Dividends per shareWRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.2 0.4 0.6 0.8 1

5.3 Sustainability

WRE pays out 876.10% of its income as dividend. This is not a sustainable payout ratio.
DP876.1%
EPS Next 2Y25.49%
EPS Next 3Y22.55%
WRE Yearly Income VS Free CF VS DividendWRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 200M -200M -400M
WRE Dividend Payout.WRE Dividend Payout, showing the Payout Ratio.WRE Dividend Payout.PayoutRetained Earnings

More info and screens

WASHINGTON REIT

NYSE:WRE (10/19/2022, 8:04:00 PM)

After market: 17.57 0 (0%)

17.57

-0.38 (-2.12%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-27 2022-10-27/amc
Earnings (Next)02-15 2023-02-15
Inst Owners88.7%
Inst Owner Change1.85%
Ins Owners0.82%
Ins Owner Change0%
Market Cap1.54B
Analysts72
Price Target23.26 (32.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.97%
Yearly Dividend0.94
Dividend Growth(5Y)-7.82%
DP876.1%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-71.62%
Min EPS beat(2)-78.22%
Max EPS beat(2)-65.02%
EPS beat(4)1
Avg EPS beat(4)-55.94%
Min EPS beat(4)-131.02%
Max EPS beat(4)50.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.75%
Min Revenue beat(2)-1.02%
Max Revenue beat(2)-0.48%
Revenue beat(4)0
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-6.14%
Max Revenue beat(4)-0.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.24
P/FCF N/A
P/OCF 26.24
P/B 1.18
P/tB 1.18
EV/EBITDA 24.9
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-3.82
FCFYN/A
OCF(TTM)0.67
OCFY3.81%
SpS2.13
BVpS14.92
TBVpS14.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.41%
ROE 0.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -1.01%
PM (TTM) 4.25%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-66.06%
OM growth 5Y-50.73%
PM growth 3Y-13.86%
PM growth 5Y-32.78%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 463.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC7.34%
ROIC/WACCN/A
Cap/Depr(3y)222.23%
Cap/Depr(5y)200.08%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.67%
EPS 3Y-15.77%
EPS 5Y-34.84%
EPS Q2Q%-25%
EPS Next Y-38.21%
EPS Next 2Y25.49%
EPS Next 3Y22.55%
EPS Next 5Y9.38%
Revenue 1Y (TTM)-37.02%
Revenue growth 3Y-16.61%
Revenue growth 5Y-11.6%
Sales Q2Q%-37.27%
Revenue Next Year10.03%
Revenue Next 2Y12.84%
Revenue Next 3Y11.27%
Revenue Next 5Y11.32%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1284.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.88%
OCF growth 3Y-15.42%
OCF growth 5Y-4.92%